In Lactobio we focus on the creation of new microbiome and microbial solutions to target and fight the problem of increasing infections caused by microorganisms being resistant to antibiotics. We work with the skin, vaginal, and gut microbiota to treat a variety of diseases – with projects spanning various pathogens. Lactobio has obtained very promising clinical results, with isolated lactic acid bacteria having a significant antibacterial activity against Staphylococcus aureus, Methicillin Resistant Staphylococcus aureus (MRSA) and other pathogens.